KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.36
+0.27 (3.34%)
At close: Dec 20, 2024, 4:00 PM
8.50
+0.14 (1.67%)
After-hours: Dec 20, 2024, 7:57 PM EST
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for KALV stock have an average target of 26.25, with a low estimate of 20 and a high estimate of 35. The average target predicts an increase of 214.00% from the current stock price of 8.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KALV stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 4 |
Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 4 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +163.16% | Dec 18, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Dec 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +139.23% | Dec 6, 2024 |
Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +234.93% | Dec 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +139.23% | Oct 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
56.29M
EPS This Year
-3.75
from -3.44
EPS Next Year
-2.64
from -3.75
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | n/a | 89.5M | 202.2M | ||
Avg | n/a | 56.3M | 152.9M | ||
Low | n/a | 40.2M | 108.4M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | 259.3% | ||
Avg | - | - | 171.6% | ||
Low | - | - | 92.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -3.57 | -1.92 | -0.02 | ||
Avg | -3.75 | -2.64 | -0.85 | ||
Low | -3.96 | -2.79 | -1.37 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.